Esta Tesis se centra en la búsqueda de nuevos sustratos de SCFbTrCP, una ligasa de ubicuitina esencial en la regulación del ciclo celular que se encuentra sobreexpresada en multitud de tumores, con el fin de hallar nuevos marcadores tumorales y/o dianas terapéuticas. Tras realizar dos escrutinios masivos determinando las proteínas que se...
-
December 1, 2022 (v1)PublicationUploaded on: March 24, 2023
-
July 19, 2022 (v1)Publication
The intra-S-checkpoint is essential to control cell progression through S phase under normal conditions and in response to replication stress. When DNA lesions are detected, replication fork progression is blocked allowing time for repair to avoid genomic instability and the risk of cancer. DNA replication initiates at many origins of...
Uploaded on: December 4, 2022 -
June 7, 2017 (v1)Publication
n mammals, cell cycle progression is controlled by cyclin-dependent kinases, among which CDK1 plays important roles in the regulation of the G2/M transition, G1 progression and G1/S transition. CDK1 is highly regulated by its association to cyclins, phosphorylation and dephosphorylation, changes in subcellular localization, and by direct...
Uploaded on: March 27, 2023 -
October 18, 2024 (v1)Publication
To ensure timely duplication of the entire eukaryotic genome, thousands of replication machineries (replisomes) act on genomic DNA at any time during S phase. In the final stages of this process, replisomes are unloaded from chromatin. Unloading is driven by polyubiquitylation of MCM7, a subunit of the terminated replicative helicase, and...
Uploaded on: October 21, 2024 -
January 12, 2022 (v1)Publication
PTTG1, also known as securin, is an inactivating partner of separase, the major effector for chromosome segregation during mitosis. At the metaphase-to-anaphase transition, securin is targeted for proteasomal destruction by the anaphase-promoting complex or cyclosome, allowing activation of separase. In addition, securin is overexpressed in...
Uploaded on: March 25, 2023 -
September 13, 2023 (v1)Publication
Cisplatin and other platinum-based anticancer agents are among the most widely used chemotherapy drugs in the treatment of different types of cancer. However, it is common to find patients who respond well to treatment at first but later relapse due to the appearance of resistance to cisplatin. Among the mechanisms responsible for this...
Uploaded on: October 11, 2023